{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:13:06Z","timestamp":1788361986376,"version":"build-2803163510"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.micpath.2026.108707","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:31:13Z","timestamp":1784244673000},"page":"108707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mesenchymal stem cells and their exosomes as novel modulators of gut microbiota: Therapeutic perspectives for liver diseases and inflammatory bowel disease"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5700-0914","authenticated-orcid":false,"given":"Khaled F.","family":"Al-Massri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108707_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/17474124.2025.2464037","article-title":"Gut microbiota: the pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease","volume":"19","author":"Scarlata","year":"2025","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.micpath.2026.108707_bib2","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1572-0241.2006.00723.x","article-title":"The burden of gastrointestinal and liver diseases, 2006","volume":"101","author":"Shaheen","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.micpath.2026.108707_bib3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/ibd\/izab183","article-title":"Insight into inflammatory bowel disease pathogenesis: is the answer blowing in the wind?","volume":"28","author":"Herman","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.micpath.2026.108707_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2971-8","article-title":"The gut microbiota is associated with immune cell dynamics in humans","volume":"588","author":"Schluter","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108707_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/IN9.0000000000000037","article-title":"Gut microbiota and metabolite interface-mediated hepatic inflammation","volume":"6","author":"Yang","year":"2024","journal-title":"Immunometabolism"},{"key":"10.1016\/j.micpath.2026.108707_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-pathol-030320-095722","article-title":"Gut microbiota in intestinal and liver disease","volume":"16","author":"Jones","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.micpath.2026.108707_bib7","doi-asserted-by":"crossref","first-page":"21660","DOI":"10.18632\/aging.103962","article-title":"Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.micpath.2026.108707_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13287-024-04013-7","article-title":"Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut\u2012liver axis","volume":"16","author":"Yang","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.micpath.2026.108707_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202400429","article-title":"Probiotics, prebiotics, fecal microbiota transplantation, and dietary patterns in inflammatory bowel disease","volume":"68","author":"Noguera\u2010Fern\u00e1ndez","year":"2024","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.micpath.2026.108707_bib11","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3390\/jcm12041683","article-title":"Research progress of fecal microbiota transplantation in liver diseases","volume":"12","author":"Zhao","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.micpath.2026.108707_bib12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10620-020-06090-z","article-title":"Microbial-based and microbial-targeted therapies for inflammatory bowel diseases","volume":"65","author":"Oka","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.micpath.2026.108707_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2174\/011574888X250413230920051715","article-title":"Impact of mesenchymal stem cells on the gut microbiota and microbiota associated functions in inflammatory bowel disease: a systematic review of preclinical evidence on animal models","volume":"19","author":"Liu","year":"2024","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2024.101958","article-title":"Mesenchymal stem cell-derived exosomes promote tissue repair injury in rats with liver trauma by regulating gut microbiota and metabolism","volume":"75","author":"Yi","year":"2024","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.micpath.2026.108707_bib15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/brv.12608","article-title":"Exosome\u2010mediated effects and applications in inflammatory bowel disease","volume":"95","author":"Ocansey","year":"2020","journal-title":"Biol. Rev."},{"key":"10.1016\/j.micpath.2026.108707_bib16","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1111\/jcmm.13208","article-title":"MiR\u2010122 modification enhances the therapeutic efficacy of adipose tissue\u2010derived mesenchymal stem cells against liver fibrosis","volume":"21","author":"Lou","year":"2017","journal-title":"Cell. Mol. Med."},{"key":"10.1016\/j.micpath.2026.108707_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jhep.2020.01.017","article-title":"Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis","volume":"72","author":"Bajaj","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.micpath.2026.108707_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.700058","article-title":"Role of the gut microbiota in regulating non-alcoholic fatty liver disease in children and adolescents","volume":"8","author":"Tokuhara","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.micpath.2026.108707_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.775526","article-title":"The gut-liver axis in health and disease: the role of gut microbiota-derived signals in liver injury and regeneration","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108707_bib20","article-title":"The role of gut microbiota in some liver diseases: from an immunological perspective","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108707_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmgh.2020.11.002","article-title":"Intestinal dysbiosis amplifies acetaminophen-induced acute liver injury","volume":"11","author":"Schneider","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.micpath.2026.108707_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis","volume":"69","author":"Wei","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.micpath.2026.108707_bib23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fcimb.2020.00342","article-title":"Fecal microbiomes distinguish patients with autoimmune hepatitis from healthy individuals","volume":"10","author":"Lou","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108707_bib24","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/microorganisms8071011","article-title":"Autoimmune hepatitis: shifts in gut microbiota and metabolic pathways among Egyptian patients","volume":"8","author":"Elsherbiny","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2026.108707_bib25","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/apt.15754","article-title":"A disease-specific decline of the relative abundance of bifidobacterium in patients with autoimmune hepatitis","volume":"51","author":"Liwinski","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.656674","article-title":"Oral microbiome characteristics in patients with autoimmune hepatitis","volume":"11","author":"Rao","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108707_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/apt.15795","article-title":"Gut microbiota profile in patients with autoimmune hepatitis\u2014a clue for adjunctive probiotic therapy?","volume":"52","author":"Granito","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib28","article-title":"A synbiotic ameliorates Con A\u2010induced autoimmune hepatitis in mice through modulation of gut microbiota and immune imbalance","volume":"67","author":"Liu","year":"2023","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.micpath.2026.108707_bib29","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.32197","article-title":"Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease","volume":"75","author":"Kwan","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.micpath.2026.108707_bib30","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1111\/jgh.15487","article-title":"Gut microbiota composition associated with hepatic fibrosis in non\u2010obese patients with non\u2010alcoholic fatty liver disease","volume":"36","author":"Iwaki","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.micpath.2026.108707_bib31","article-title":"Phillygenin attenuates carbon tetrachloride-induced liver fibrosis via modulating inflammation and gut microbiota","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108707_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.70005","article-title":"Melatonin ameliorates cadmium\u2010induced liver fibrosis via modulating gut microbiota and bile acid metabolism","volume":"76","author":"Liu","year":"2024","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.micpath.2026.108707_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.micpath.2026.108707_bib34","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s11154-023-09843-z","article-title":"Non-alcoholic fatty liver disease and gut microbial dysbiosis-underlying mechanisms and gut microbiota mediated treatment strategies","volume":"24","author":"Jayachandran","year":"2023","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.micpath.2026.108707_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00535-023-02075-7","article-title":"Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism","volume":"59","author":"Cornejo-Pareja","year":"2024","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.micpath.2026.108707_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.20517\/2394-5079.2023.134","article-title":"Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease","volume":"10","author":"Colaci","year":"2024","journal-title":"Hepatom. Res."},{"key":"10.1016\/j.micpath.2026.108707_bib37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13287-022-03010-y","article-title":"Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6\/STAT3 pathway in macrophages","volume":"13","author":"Tian","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/pathogens8030126","article-title":"Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome","volume":"8","author":"Khan","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2026.108707_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","article-title":"The microbiome and inflammatory bowel disease","volume":"145","author":"Glassner","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.micpath.2026.108707_bib40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3748\/wjg.v17.i5.557","article-title":"Intestinal microbiota in inflammatory bowel disease: friend of foe?","volume":"17","author":"Fava","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.micpath.2026.108707_bib41","first-page":"270","article-title":"Dysbiosis of gut microbiota in inflammatory bowel disease: current therapies and potential for microbiota-modulating therapeutic approaches","volume":"21","author":"Alshehri","year":"2021","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.micpath.2026.108707_bib42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2174\/1574888X19666230918102826","article-title":"Mesenchymal stem cell-derived exosomes mitigate acute murine liver injury via ets-1 and heme oxygenase-1 up-regulation","volume":"19","author":"Kao","year":"2024","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1661386","article-title":"Systemic dysregulation of the gut microenvironment plays a pivotal role in the onset and progression of inflammatory bowel disease","volume":"16","author":"Kou","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108707_bib44","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biol."},{"key":"10.1016\/j.micpath.2026.108707_bib45","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/nutrit\/nuab059","article-title":"Short-chain fatty acids as anti-inflammatory agents in overweight and obesity: a systematic review and meta-analysis","volume":"80","author":"Eslick","year":"2022","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.micpath.2026.108707_bib46","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1128\/AEM.06035-11","article-title":"Characterization of Phascolarctobacterium succinatutens sp. Nov., an asaccharolytic, succinate-utilizing bacterium isolated from human feces","volume":"78","author":"Watanabe","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.micpath.2026.108707_bib47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","article-title":"Induction of colonic regulatory T cells by indigenous Clostridium species","volume":"331","author":"Atarashi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.micpath.2026.108707_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-230X-13-20","article-title":"Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case\u2013control study in India","volume":"13","author":"Kabeerdoss","year":"2013","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.micpath.2026.108707_bib49","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2026.108707_bib50","doi-asserted-by":"crossref","first-page":"18497","DOI":"10.1021\/acs.jafc.4c03486","article-title":"Clostridium tyrobutyricum in combination with chito-oligosaccharides modulate inflammation and gut microbiota for inflammatory bowel disease treatment","volume":"72","author":"Liu","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.micpath.2026.108707_bib51","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108707_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.71157","article-title":"Advancements in immunomodulatory therapies for IBD and their interplay with the gut\u2013brain axis: an updated review of current literature and beyond","volume":"8","author":"Jha","year":"2025","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108707_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12712","article-title":"Immune modulation by mesenchymal stem cells","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.micpath.2026.108707_bib54","doi-asserted-by":"crossref","first-page":"858","DOI":"10.2174\/1574888X16666210303151237","article-title":"Directions for enhancement of the therapeutic efficacy of mesenchymal stem cells in different neurodegenerative and cardiovascular diseases: current status and future perspectives","volume":"16","author":"Ahmed","year":"2021","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib55","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1007\/s10787-023-01350-6","article-title":"Innovative preconditioning strategies for improving the therapeutic efficacy of extracellular vesicles derived from mesenchymal stem cells in gastrointestinal diseases","volume":"31","author":"Didamoony","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.micpath.2026.108707_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102359","article-title":"Benefits of conditioned medium of nicotine-pulsed mesenchymal stem cells in experimental autoimmune hepatitis","volume":"88","author":"Mahmoudzadeh","year":"2024","journal-title":"Tissue Cell"},{"key":"10.1016\/j.micpath.2026.108707_bib58","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.2147\/IJN.S472086","article-title":"Metabolic reprogramming of CD4+ T cells by mesenchymal stem cell-derived extracellular vesicles attenuates autoimmune hepatitis through mitochondrial protein transfer","volume":"19","author":"Shen","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2026.108707_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.650376","article-title":"Mesenchymal stem cells-derived exosomes as dexamethasone delivery vehicles for autoimmune hepatitis therapy","volume":"9","author":"Zhao","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108707_bib57","first-page":"906","article-title":"Attenuation of experimental autoimmune hepatitis in mice with bone mesenchymal stem cell-derived exosomes carrying MicroRNA-223-3p","volume":"42","author":"Lu","year":"2019","journal-title":"Mol. Cells"},{"key":"10.1016\/j.micpath.2026.108707_bib56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2017.11.008","article-title":"BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis","volume":"93","author":"Chen","year":"2018","journal-title":"Mol. Immunol."},{"issue":"333","key":"10.1016\/j.micpath.2026.108707_bib69","first-page":"hcae175","article-title":"Effect of exosomes derived from mesenchymal stem cell on hepatic regeneration in carbon tetrachloride induced acute liver injury in adult male albino rats","volume":"117","author":"Lotfy Ali","year":"2024","journal-title":"Histological study, QJM: Int. J. Med."},{"key":"10.1016\/j.micpath.2026.108707_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1157793","article-title":"Mesenchymal stem cell-derived exosome alleviates sepsis-associated acute liver injury by suppressing MALAT1 through microRNA-26a-5p: an innovative immunopharmacological intervention and therapeutic approach for sepsis","volume":"14","author":"Cai","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108707_bib93","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41419-022-04708-w","article-title":"Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury","volume":"13","author":"Lin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.micpath.2026.108707_bib94","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8287227","article-title":"Exosomes derived from baicalin-pretreated mesenchymal stem cells alleviate hepatocyte ferroptosis after acute liver injury via the Keap1-NRF2 pathway","volume":"2022","author":"Zhao","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.micpath.2026.108707_bib76","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12951-025-03291-4","article-title":"Exosomal miR-499a-5p from human umbilical cord mesenchymal stem cells attenuates liver fibrosis via targeting ETS1\/GPX4-mediated ferroptosis in hepatic stellate cells","volume":"23","author":"Wang","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.micpath.2026.108707_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112934","article-title":"Exploring the cytoprotective role of mesenchymal stem cell-derived exosomes in chronic liver fibrosis: insights into the Nrf2\/Keap1\/p62 signaling pathway","volume":"141","author":"Al Saihati","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.micpath.2026.108707_bib78","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s12072-024-10717-y","article-title":"Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog\/SMO signaling","volume":"18","author":"Zong","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.micpath.2026.108707_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10565-022-09714-4","article-title":"hMSCs-derived exosome circCDK13 inhibits liver fibrosis by regulating the expression of MFGE8 through miR-17-5p\/KAT2B","volume":"39","author":"Ma","year":"2023","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.micpath.2026.108707_bib85","first-page":"334","article-title":"The ameliorative effect of adipose-derived mesenchymal stem cells and their exosomes in non-alcoholic steatohepatitis by simultaneously enhancing autophagic flux and suppressing endoplasmic reticulum stress","volume":"50","author":"Moayedfard","year":"2025","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.micpath.2026.108707_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/jfbc\/6134296","article-title":"Curcumin\u2010loaded mesenchymal stem cell\u2010derived exosomes: a potential effective strategy for NAFLD","volume":"2025","author":"Luo","year":"2025","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.micpath.2026.108707_bib91","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13287-025-04228-2","article-title":"Mesenchymal stem cell-derived small extracellular vesicles reduced hepatic lipid accumulation in MASLD by suppressing mitochondrial fission","volume":"16","author":"Chen","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib88","article-title":"Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis","volume":"5","author":"Yang","year":"2023","journal-title":"JHEP Rep."},{"key":"10.1016\/j.micpath.2026.108707_bib82","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/21623945.2022.2098583","article-title":"Adipose-derived mesenchymal stem cell-secreted extracellular vesicles alleviate non-alcoholic fatty liver disease via delivering miR-223-3p","volume":"11","author":"Niu","year":"2022","journal-title":"Adipocyte"},{"key":"10.1016\/j.micpath.2026.108707_bib110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13287-024-04062-y","article-title":"Efficacy of umbilical cord-derived mesenchymal stem cells and exosomes in conjunction with standard IBD drug on immune responses in an IBD mouse model","volume":"16","author":"Kheradmand","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib108","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13287-025-04365-8","article-title":"Human umbilical cord mesenchymal stem cell-derived exosomes repair IBD by activating the SIRT1-FXR pathway in macrophages","volume":"16","author":"Zhou","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib109","article-title":"Bone marrow mesenchymal stem cell-derived exosomes alleviate dss-induced inflammatory bowel disease in mice through inhibiting intestinal epithelial cell pyroptosis via delivery of TSG-6","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108707_bib112","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.62347\/EXZE5413","article-title":"HucMSC-Ex alleviates DSS-induced colitis in mice by decreasing mast cell activation via the IL-33\/ST2 axis","volume":"16","author":"Wei","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.micpath.2026.108707_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316877","article-title":"The anti-inflammatory effects of adipose tissue mesenchymal stem cell exosomes in a mouse model of inflammatory bowel disease","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108707_bib114","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/01913123.2022.2039825","article-title":"Effect of mesenchymal stem cells derived exosomes and green tea polyphenols on acetic acid induced ulcerative colitis in adult male albino rats","volume":"46","author":"El-Desoky Mohamady","year":"2022","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.micpath.2026.108707_bib103","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s13287-021-02492-6","article-title":"hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p\/NLRP3 axis","volume":"12","author":"Cai","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib104","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13287-021-02404-8","article-title":"A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6","volume":"12","author":"Yang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib115","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1002\/jcp.30275","article-title":"Adipose\u2010derived mesenchymal stem cell\u2010secreted exosome alleviates dextran sulfate sodium\u2010induced acute colitis by Treg cell induction and inflammatory cytokine reduction","volume":"236","author":"Heidari","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.micpath.2026.108707_bib116","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.14336\/AD.2021.0601","article-title":"Human adipose mesenchymal stem cell-derived exosomes protect mice from DSS-induced inflammatory bowel disease by promoting intestinal-stem-cell and epithelial regeneration","volume":"12","author":"Yu","year":"2021","journal-title":"Aging Dis"},{"key":"10.1016\/j.micpath.2026.108707_bib60","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/jpp\/rgac071","article-title":"Bromelain ameliorates D-galactosamine-induced acute liver injury: role of SIRT1\/LKB1\/AMPK, GSK3beta\/Nrf2 and NF-kappaB p65\/TNF-alpha\/caspase-8, -9 signalling pathways","volume":"74","author":"Didamoony","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108707_bib61","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL clinical practical guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"Wendon","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.micpath.2026.108707_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120730","article-title":"Is human umbilical cord mesenchymal stem cell-derived conditioned medium effective against oxidative and inflammatory status in CCl4-induced acute liver injury?","volume":"305","author":"Basir","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.micpath.2026.108707_bib63","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ebiom.2018.08.054","article-title":"AMSC-derived exosomes alleviate lipopolysaccharide\/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP\/NLRP3 inflammasome activation in macrophages","volume":"36","author":"Liu","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.micpath.2026.108707_bib64","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.2147\/DDDT.S220190","article-title":"Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN\/LPS-induced hepatocyte apoptosis by activating autophagy in vitro","volume":"13","author":"Zhao","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jphs.2021.06.008","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acetaminophen-induced acute liver failure through activating ERK and IGF-1R\/PI3K\/AKT signaling pathway","volume":"147","author":"Wu","year":"2021","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.micpath.2026.108707_bib66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ymthe.2016.11.019","article-title":"hucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury","volume":"25","author":"Yan","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib68","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbrc.2018.11.189","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acute liver failure by reducing the activity of the NLRP3 inflammasome in macrophages","volume":"508","author":"Jiang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2026.108707_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.671640","article-title":"Cellular mechanisms of liver fibrosis","volume":"12","author":"Acharya","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108707_bib71","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13287-019-1204-2","article-title":"Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/beta-catenin pathway","volume":"10","author":"Rong","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib72","article-title":"Unravelling the reversion mechanisms of activated hepatic stellate cell properties by extracellular vesicles from mesenchymal stem cells, World J","volume":"17","author":"Islam","year":"2025","journal-title":"Stem Cell."},{"key":"10.1016\/j.micpath.2026.108707_bib73","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/jcmm.16119","article-title":"Extracellular vesicles\u2010derived miR\u2010150\u20105p secreted by adipose\u2010derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis","volume":"25","author":"Du","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.micpath.2026.108707_bib74","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1111\/jcmm.13170","article-title":"Exosomes derived from miR\u2010181\u20105p\u2010modified adipose\u2010derived mesenchymal stem cells prevent liver fibrosis via autophagy activation","volume":"21","author":"Qu","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.micpath.2026.108707_bib75","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1177\/0960327120931152","article-title":"Exosomes derived from mmu_circ_0000623-modified ADSCs prevent liver fibrosis via activating autophagy","volume":"39","author":"Zhu","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.micpath.2026.108707_bib79","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13287-022-02929-6","article-title":"The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles","volume":"13","author":"Moayedfard","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib80","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/jcp.30699","article-title":"The role of exosomal miRNA in nonalcoholic fatty liver disease","volume":"237","author":"Mahmoudi","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.micpath.2026.108707_bib81","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbrc.2022.11.012","article-title":"Mesenchymal stem cells-derived exosomal miR-24-3p ameliorates non-alcohol fatty liver disease by targeting Keap-1","volume":"637","author":"Du","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2026.108707_bib83","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s13577-021-00593-1","article-title":"Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression","volume":"34","author":"Cheng","year":"2021","journal-title":"Hum. Cell"},{"key":"10.1016\/j.micpath.2026.108707_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114624","article-title":"Upregulation of miR-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: emphasis on caspase-2 signaling inhibition","volume":"190","author":"El-Derany","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108707_bib86","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s13287-022-03201-7","article-title":"Human umbilical cord mesenchymal stromal cell-derived exosomes protect against MCD-induced NASH in a mouse model","volume":"13","author":"Shi","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib87","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3212643","article-title":"Extracellular vesicles from amnion\u2010derived mesenchymal stem cells ameliorate hepatic inflammation and fibrosis in rats","volume":"2018","author":"Ohara","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.micpath.2026.108707_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101837","article-title":"Curcumin preconditioned mesenchymal stem cells derived exosomes transplantation ameliorate and protect against non- alcoholic steatohepatitis by regulation the expression of key genes of inflammation and oxidative stress","volume":"78","author":"Tawfeek","year":"2023","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.micpath.2026.108707_bib90","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13287-025-04197-6","article-title":"Huc-MSCs-derived exosomes alleviate non-alcoholic steatohepatitis by regulating macrophages polarization through miR-24-3p\/STING axis","volume":"16","author":"Jiang","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib97","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study","volume":"395","author":"Ol\u00e9n","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2026.108707_bib98","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.lfs.2015.07.004","article-title":"Geraniol ameliorates TNBS-induced colitis: involvement of Wnt\/\u03b2-catenin, p38MAPK, NF\u03baB, and PPAR\u03b3 signaling pathways","volume":"136","author":"Soubh","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.micpath.2026.108707_bib99","article-title":"Extracellular vesicles derived from bone marrow mesenchymal stem cells protect against experimental colitis via attenuating colon inflammation, oxidative stress and apoptosis","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108707_bib100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s11658-025-00810-x","article-title":"Human umbilical cord mesenchymal stromal cell-derived exosomes alleviate antibiotic-induced intestinal barrier damage by regulating autophagy via the S100G\/mTOR signaling pathway","volume":"30","author":"Guo","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.micpath.2026.108707_bib101","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5356760","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice","volume":"2017","author":"Mao","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.micpath.2026.108707_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.113","article-title":"HucMSC-exosomes carrying miR-326 inhibit neddylation to relieve inflammatory bowel disease in mice","volume":"10","author":"Wang","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.micpath.2026.108707_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.598322","article-title":"Olfactory Ecto-mesenchymal stem cell-derived exosomes ameliorate experimental colitis via modulating Th1\/Th17 and treg cell responses","volume":"11","author":"Tian","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108707_bib106","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.intimp.2019.04.020","article-title":"Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization","volume":"72","author":"Cao","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.micpath.2026.108707_bib107","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12951-023-01951-x","article-title":"Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis","volume":"21","author":"Wei","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.micpath.2026.108707_bib111","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jcis.2024.05.162","article-title":"Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis therapy","volume":"671","author":"Deng","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.micpath.2026.108707_bib117","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.3390\/ijms25063278","article-title":"Inflammatory bowel diseases and non-alcoholic fatty liver disease: piecing a complex puzzle together","volume":"25","author":"Maresca","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108707_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00445","article-title":"Extracellular vesicles from mesenchymal stem cells alter gut microbiota and improve neuroinflammation and motor impairment in rats with mild liver damage","volume":"21","author":"Mincheva","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.micpath.2026.108707_bib119","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11274-025-04395-7","article-title":"The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health","volume":"41","author":"Tyagi","year":"2025","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108707_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2026.1747341","article-title":"The role of bile acid-activated receptor TGR5 in inflammation and liver diseases","volume":"17","author":"Xiang","year":"2026","journal-title":"Front. Physiol."},{"key":"10.1016\/j.micpath.2026.108707_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/ph17050607","article-title":"Therapeutic prospects of mesenchymal stem cell and their derived exosomes in the regulation of the gut microbiota in inflammatory bowel disease","volume":"17","author":"Qiao","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.micpath.2026.108707_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2026.1832332","article-title":"The gut microbiota-bile acid axis in liver transplantation: implications for postoperative complications and therapeutic strategies","volume":"17","author":"Xia","year":"2026","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108707_bib123","doi-asserted-by":"crossref","first-page":"843","DOI":"10.20517\/evcna.2025.95","article-title":"Adipose-derived stem cell extracellular vesicles attenuate liver fibrosis via restoration of gut barrier function and modulation of gut microbiota","volume":"6","author":"Wu","year":"2025","journal-title":"Extracell. Vesicles Circ. Nucleic Acids"},{"key":"10.1016\/j.micpath.2026.108707_bib124","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2147\/JIR.S402592","article-title":"Mesenchymal stem cells ameliorate dss-induced experimental colitis by modulating the gut microbiota and MUC-1 pathway","volume":"16","author":"Wang","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.micpath.2026.108707_bib125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13287-023-03471-9","article-title":"Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis","volume":"14","author":"Liu","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2026.108707_bib126","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1039\/D2BM00559J","article-title":"Mesenchymal stem cell-derived exosome mitigates colitis via the modulation of the gut metagenomics\u2013metabolomics\u2013farnesoid X receptor axis","volume":"10","author":"Ocansey","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.micpath.2026.108707_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.660614","article-title":"Exosomal MicroRNA-181a derived from mesenchymal stem cells improves gut microbiota composition, barrier function, and inflammatory status in an experimental colitis model","volume":"8","author":"Gu","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.micpath.2026.108707_bib128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/stem.3061","article-title":"Preclinical translation of exosomes derived from mesenchymal stem\/stromal cells","volume":"38","author":"Elahi","year":"2020","journal-title":"Stem Cell."},{"key":"10.1016\/j.micpath.2026.108707_bib129","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.3390\/ijms15034142","article-title":"Exosomes derived from mesenchymal stem cells","volume":"15","author":"Yu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108707_bib130","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4245704","article-title":"Mesenchymal stem cell\u2010derived exosomes: novel therapeutic approach for inflammatory bowel diseases","volume":"2023","author":"Tian","year":"2023","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.micpath.2026.108707_bib131","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3934\/celltissue.2018.2.78","article-title":"Biological properties of mesenchymal stem cells derived from adipose tissue, umbilical cord tissue and bone marrow","volume":"2","author":"Mahmood","year":"2018","journal-title":"AIMS Cell Tissue Eng"},{"key":"10.1016\/j.micpath.2026.108707_bib132","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/5584_2018_306","article-title":"Molecular mechanisms responsible for anti-inflammatory and immunosuppressive effects of mesenchymal stem cell-derived factors","volume":"1084","author":"Harrell","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.micpath.2026.108707_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27093751","article-title":"Research advances on mesenchymal stem cell-derived exosomes in anti-graft-versus-host disease therapy: mechanisms, therapeutic potential, and future prospects","volume":"27","author":"Pan","year":"2026","journal-title":"Int. J. Mol. Sci."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102600433X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102600433X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:19:39Z","timestamp":1788358779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240102600433X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":133,"alternative-id":["S088240102600433X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108707","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cells and their exosomes as novel modulators of gut microbiota: Therapeutic perspectives for liver diseases and inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108707"}}